- Home
- #ChangingRisk
- Sections
- Topics
- Editions
- Events
Healthcare Life Sciences Pharma
Healthcare leads data risk assessments – Trustwave study
UK professionals value their personally identifiable data at less than half as much as their US counterparts, according to a report from tech firm Trustwave
Germany exempted from mandatory rebates for pharmaceutical companies
The European Commission found that the scheme pursues an objective of common interest
Healthcare in Africa improves amid Ebola outbreak
International SOS’ analysis reveals the world’s most dangerous locations concerning health risk
Ebola: EU announces medium/long-term support through development co-operation
Efforts should ultimately help contain, control, treat and defeat the disease
Does your insurance cover you for Ebola-related claims?
With the disease spreading further and further, corporate policyholders would be wise to assess their insurance coverage
EU to boost Ebola research with €24.4m
Funding to go to five projects via a fast-track procedure
Q&A: Ebola and the health implications for the EU
With the number of cases now having reached more than 8,000, the EU has issued a Q&A on the deadly virus
ACE addresses growing casualty exposures in Europe’s life science industry
Insurer aims to support life science firms in Continental Europe with an enhanced proposition that includes catastrophe management
Ebola outbreak could affect supply chains
Businesses need to consider in more detail the wider impact on their operations of outbreaks of infectious diseases